Newsroom

The latest news and stats on sleep apnea and respiratory care from
ResMed, the world's leading tech-driven medical device company. 

Meet AirFit F30: The latest in our line of full face CPAP masks

Read the press release

Meet AirFit F30: The latest in our line of full face CPAP masks

Read the press release

Latest news

Latest news

December 10, 2018

SAN DIEGO – December 10, 2018 – ResMed (NYSE: RMD, ASX: RMD), a leader in cloud-connected medical devices and out-of-hospital software-as-a-service (SaaS) business solutions, today was named...

December 6, 2018

Springfield, Mo. – December 6, 2018 – HEALTHCAREfirst, a leading provider of web-based home health and hospice software, billing and coding services, CAHPS surveys, and advanced analytics,...

December 3, 2018

SAN DIEGO – December 3, 2018 – ResMed (NYSE: RMD, ASX: RMD), a leader in cloud-connected medical devices and out-of-hospital software-as-a-service (SaaS) business solutions, today announced it...

See all news releases

Fast facts - Landing Page

Fast facts

  • +1.5 MILLION
    people use myAir to self monitor their CPAP treatment
  • +6 MILLION
    people remotely monitored on cloud connected CPAP machines and ventilators every night
  • +14 MILLION
    lives changed by a ResMed device, mask or accessory

See all fast facts

In the news

In the news

October 29, 2018
Med Device Online
October 15, 2018
Health Europa

See all articles

Infographics - Landing Page

Infographics

Learn about respiratory conditions, their effects on our health and communities,
and how ResMed helps millions live and breathe better.

 

See all infographics

Media resources - Gray, Left - Landing Page

Media resources

Find everything you need.
Ask us for more information.

See all resources

Media contacts - Gray, Right - Landing Page

Media contact

Jayme Rubenstein
(858) 836-6798

news@resmed.com

 

Email Alerts - Landing Page

Sign up to receive ResMed news releases when they publish.

Subscribe

 

ResMed provides a non-transferable, non-exclusive license to the copyrighted images, drawings and materials subject to the following Terms of Use.

All countries & languages